Tula, Tula, Russian Federation
Tula, Tula, Russian Federation
UDC 61
Osteoporosis (OP) occupies one of the leading places in the morbidity structure among people over 50 years of age, and its social significance is associated with the main complications – low-energy fractures of the vertebral bodies and bones of the peripheral skeleton, which lead to an increase in disability and mortality among the population, being a serious problem for public health. This article examines a clinical case of severe osteoporosis in a 53-year-old man, which in a short time led to several pathological fractures of the axial skeleton, accompanied by persistent pain and impaired walking.
osteoporosis, BMD, FRAX, X-ray densitometry, bisphosphonates, clinical case
1. Federal'nye klinicheskie rekomendacii po diagnostike, lecheniyu i profilaktike osteoporoza // Osteoporoz i osteopatii. — 2021. — T. 24. — №2. — S. 4-47.
2. Shutova A.S., Fedina E.A., Kuz'min A.G., Pigarova E.A., Przhiyalkovskaya E.G., Litvinova E.E., Shutova N.A. Dzeranova L.K. Neochevidnost' prichin vtorichnogo osteoporoza na primere real'nogo klinicheskogo sluchaya // Ozhirenie i metabolizm. – 2023. – T. 20. – №3. – C. 269-273.
3. Biryukova E.V., Shinkin M.V. Muzhskoe zdorov'e i osteoporoz: sovremennye vozmozhnosti lecheniya i profilaktiki. Medicinskiy sovet. 2021;(21-1):120–129.
4. Baranova IA, Suleymanova AK, Zaharova VV. Diagnostika osteoporoza u pacientov s hronicheskoy obstruktivnoy bolezn'yu legkih: ocenka individual'noy 10-letney veroyatnosti perelomov (FRAX) i dvuenergeticheskaya rentgenovskaya absorbciometriya. Pul'monologiya. 2021;31(3):338-347.
5. Gladkova EN, Tanaev VG, Lesnyak OM, Zabezhinskaya IV, Ilyushin YuM, Kolbin MYu. Effektivnost' skrininga na vyyavlenie pacientov s osteoporozom/vysokim riskom perelomov v usloviyah pervichnoy mediko-sanitarnoy pomoschi. Osteoporoz i osteopatii. 2022;25(1):14-22.
6. Machehina L.V., Dudinskaya E.N., Tkacheva O.N., Hovasova N.O. Lechenie tyazhelogo osteoporoza v starcheskom vozraste: vozmozhnosti kostno-anabolicheskoy terapii. Rossiyskiy zhurnal geriatricheskoy mediciny. 2021; 2(6)
7. Rodionova S.S., Kolondaev A.F., Torgashin A.N., Solomyannik I.A. Zoledronovaya kislota pri osteoporoze i nizkoenergeticheskih perelomah, oslozhnyayuschih ego techenie. Medicinskiy sovet. 2022;16(21):163–173.
8. Lesnyak O.M. Osteoporoz u muzhchin — problema, nedoocenennaya klinicheskoy medicinoy // Effektivnaya farmakoterapiya. — 2016. — 17. — S. 28-32.
9. Golovach I.Yu., Egudina E.D. Osteoporoz u muzhchin: sostoyanie problemy, faktory riska, diagnostika, sovremennye podhody k lecheniyu. Travma. 2019.
10. Ozasa R., Saito M., Ishimoto T., Matsugaki A., Matsumoto Y., Nakano T. Combination treatment with ibandronate and eldecalcitol prevents osteo porotic bone loss and deterioration of bone quality characterized by nano-arrangement of the collagen/apatite in an ovariectomized aged rat model. Bone. 2022;157:116309.
11. Salari N., Ghasemi H., Mohammadi L., Behzadi M.H., Rabieenia E., Shohaimi S., Mohammadi M. The global prevalence of osteoporosis in the world: a com prehensive systematic review and meta-analysis. J Orthop Surg Res. 2021;16(1):609.
12. Gaudio A, Xourafa A, Rapisarda R, et al. Hematological diseases and osteoporosis. Int J Mol Sci. 2020;21(10):3538.
